Loading...

Intellectia LogoIntellectia
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. XWEL
XWEL logo

XWEL Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • AI Stock Picker
  • Swing Trading
  • SwingMax Portfolio
  • QuantAI Alpha Pick
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • Financial AI Agent
  • AI Screener
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
1.635
Open
1.360
VWAP
1.48
Vol
1.92M
Mkt Cap
8.36M
Low
1.360
Amount
2.85M
EV/EBITDA(TTM)
--
Total Shares
5.77M
EV
13.29M
EV/OCF(TTM)
--
P/S(TTM)
0.25
XWELL, Inc. is a global wellness holding company. The Company operates through four segments: XpresSpa, XpresTest, Naples Wax Center and Treat. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresCheck segment, in partnership with the Centers for Disease Control and Prevention (CDC) and Ginkgo Biosecurity, conducts biosurveillance monitoring in its airport locations. XpresTest’s HyperPointe business provides a range of service and support options for its customers, including technical support services and advanced services. The Naples Wax Center segment operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products. The Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers.
Show More

Events Timeline

(ET)
2026-02-03
08:30:00
Xwell Partners with PieQ for Biosecurity Forecasting Platform
select
2026-01-08 (ET)
2026-01-08
08:30:00
XWELL Expands Global Biosecurity Strategy, Appoints Former CDC Advisor as Senior Advisor
select
2025-12-18 (ET)
2025-12-18
08:20:00
XWELL Opens New Location in New York's Pennsylvania Station
select
2025-11-05 (ET)
2025-11-05
08:20:18
Xwell and Ostrichpillow Introduce Collaborative Eye Mask
select
2025-10-30 (ET)
2025-10-30
08:18:43
Xwell partners with Priority Pass for global expansion
select
2025-09-12 (ET)
2025-09-12
08:05:33
Xwell Unveils New Bloomingdale Wellness Center Opening
select
2025-08-11 (ET)
2025-08-11
08:08:30
Xwell regains compliance with Nasdaq min bid price requirement
select
2025-07-29 (ET)
2025-07-29
08:11:24
Xwell launches newly redesigned website
select

News

Benzinga
8.5
02-25Benzinga
XWELL Shares Surge 221% Following $31.3 Million Private Placement Announcement
  • Significant Financing: XWELL has entered into a securities purchase agreement with American Ventures to raise approximately $31.3 million through the issuance of Series H Convertible Preferred Stock, which is expected to significantly enhance the company's capital structure and liquidity.
  • Stock Price Surge: XWELL shares surged 221.43% on Wednesday, closing at $1.22, reflecting strong market optimism regarding the financing, which may attract more investor interest.
  • Clear Use of Proceeds: The company plans to utilize the raised funds to repurchase $5.95 million of certain notes and redeem its Series G preferred stock, with a total cash outlay of $9 million, which will help reduce financial costs and optimize its capital structure.
  • Transaction Completion Imminent: The private placement is anticipated to close on or around Thursday, further boosting market confidence in XWELL's future growth potential and potentially laying a solid foundation for the company's subsequent development.
stocktwits
8.5
02-25stocktwits
XWELL Completes $31.3 Million Private Placement
  • Private Placement Details: XWELL signed a securities purchase agreement with American Ventures to sell 31,333 shares of Series H Preferred Stock at $1,000 each, with the transaction expected to close on February 26, 2026, and proceeds earmarked for repurchasing $6 million in notes and redeeming certain preferred shares.
  • Stock Performance Recovery: XWEL shares surged above $1 for the first time since October 28, 2025, indicating a recovery after receiving a Nasdaq minimum bid price deficiency notice, as the company aims to maintain its stock price to avoid delisting risks.
  • Market Sentiment Shift: Retail sentiment on Stocktwits shifted from 'bearish' to 'extremely bullish', with expectations for the stock to rise to $2, reflecting increased investor confidence in the company's future performance, as the stock has gained nearly 220% year-to-date.
  • Clear Use of Funds: The funds from this transaction will be used to repurchase warrants covering 8.8 million common shares for $9 million, while the remaining proceeds will support general business expenses and working capital, demonstrating the company's focus on financial health.
Benzinga
9.5
02-25Benzinga
U.S. Stocks Rise as TJX Reports Strong Earnings Beat
  • Market Performance: U.S. stocks broadly rose on Wednesday, with the Nasdaq Composite gaining over 250 points, indicating improved market sentiment, particularly as technology shares increased by 1.6%, reflecting heightened investor confidence in the tech sector.
  • TJX Earnings Report: TJX Companies reported fourth-quarter earnings of $1.43 per share, surpassing analyst expectations of $1.39, with sales reaching $17.743 billion, also exceeding the consensus estimate of $17.370 billion, showcasing the company's robust performance in retail.
  • Future Outlook: Despite TJX's FY2027 GAAP EPS guidance of $4.93 to $5.02 falling short of the market estimate of $5.17, the strong quarterly results may still attract investor interest, reflecting the company's resilience in an uncertain market environment.
  • Economic Data: The volume of mortgage applications in the U.S. increased by 0.4% in the third week of February, although this was lower than the previous week's 2.8% gain, indicating a gradual recovery in the housing market that could positively impact future economic growth.
Benzinga
9.5
02-25Benzinga
U.S. Stocks Rise in Morning Trading, Dow Jones Up Over 200 Points
  • Strong Dow Performance: The Dow Jones index gained over 200 points on Wednesday, rising 0.41% to close at 49,375.99, indicating positive market sentiment and increased investor confidence.
  • NASDAQ and S&P 500 Rise: The NASDAQ surged 0.77% to 23,040.20, while the S&P 500 rose 0.55% to 6,928.15, reflecting strong performances in technology and other major sectors.
  • Lowe's Earnings Beat Expectations: Lowe's reported Q4 earnings of $1.98 per share, exceeding analyst expectations of $1.94, with sales of $20.584 billion also surpassing the consensus estimate of $20.334 billion, although the company issued weaker future earnings guidance.
  • Energy Stocks Decline: Energy stocks fell by 0.3% on Wednesday, contrasting with a 0.8% rise in information technology shares, indicating a divergence in market performance that could influence investor asset allocation strategies.
Newsfilter
7.5
02-25Newsfilter
Totaligent Forms Joint Venture with GloMed for Biologics Distribution
  • Strategic Partnership: Totaligent has signed a binding Letter of Intent with Japan's GloMed Solutions to establish a joint venture that integrates Totaligent's Aetherium medical platform with GloMed's distribution infrastructure, aiming to accelerate biologics adoption in the APAC market, with the transaction expected to close in approximately four weeks.
  • Capital Structure Reset: XWELL announced a $31.3 million private placement aimed at repurchasing $5.96 million in outstanding notes and redeeming Series G Preferred Stock, indicating a strategic effort to simplify its balance sheet, with closing expected around February 26.
  • AI Drug Discovery Validation: Recursion Pharmaceuticals reported Q4 and full-year 2025 results, highlighting clinical validation of its AI-driven drug discovery platform, with REC-4881 showing 75% efficacy in familial adenomatous polyposis patients, reinforcing the company's leadership in the biotech sector.
  • Revenue Growth Expectations: NextPlat projects approximately $55 million in revenue for 2025, with Q4 340B revenue expected to increase over 90%, and anticipates gross margin expansion of 20%-25% in 2026, reflecting a strategic shift towards revenue quality and cost control.
Benzinga
9.5
02-25Benzinga
Axon Reports Q4 Revenue and Earnings Beat Estimates
  • Significant Revenue Growth: Axon reported fourth-quarter revenue of $796.72 million, surpassing analyst expectations of $755.40 million, indicating strong market performance and sustained growth potential for the company.
  • Improved Profitability: The company posted adjusted earnings of $2.15 per share, significantly exceeding the analyst estimate of $1.60 per share, reflecting Axon's success in cost control and operational efficiency.
  • Stock Price Surge: Axon's shares jumped 16.2% in pre-market trading to $514.21, demonstrating a positive market reaction to its earnings report and indicating increased investor confidence in the company's future prospects.
  • Market Impact Analysis: This earnings beat not only enhances Axon's market valuation but may also attract more investor attention, further solidifying the company's leadership position in the security technology sector.

Valuation Metrics

The current forward P/E ratio for XWELL Inc (XWEL.O) is -0.17, compared to its 5-year average forward P/E of -1.83. For a more detailed relative valuation and DCF analysis to assess XWELL Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-1.83
Current PE
-0.17
Overvalued PE
4.34
Undervalued PE
-7.99

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-2.28
Current EV/EBITDA
-2.02
Overvalued EV/EBITDA
2.15
Undervalued EV/EBITDA
-6.72

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.02
Current PS
0.07
Overvalued PS
2.15
Undervalued PS
-0.11

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

news about stocks that are below 10 dollar
Intellectia · 100 candidates
Region: USPrice: $1.00 - $10.00Relative Vol: >= 2List Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 2,000,000News Driver: Positive, Negative
Ticker
Name
Market Cap$
top bottom
XWEL logo
XWEL
XWELL Inc
6.98M
LRMR logo
LRMR
Larimar Therapeutics Inc
494.39M
VSME logo
VSME
VS Media Holdings Ltd
5.06M
EVH logo
EVH
Evolent Health Inc
350.52M
NVTS logo
NVTS
Navitas Semiconductor Corp
2.27B
SBET logo
SBET
Sharplink Inc
1.46B
low float high volume
Intellectia · 49 candidates
Region: USVolume: >= 500,000Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEFloating Shares: <= 20,000,000
Ticker
Name
Market Cap$
top bottom
FAT logo
FAT
FAT Brands Inc
5.25M
APRE logo
APRE
Aprea Therapeutics Inc
5.57M
FATBB logo
FATBB
FAT Brands Inc
27.81M
YCBD logo
YCBD
cbdMD Inc
10.92M
LXEH logo
LXEH
Lixiang Education Holding Co Ltd
6.50M
KXIN logo
KXIN
Kaixin Holdings
29.77M
low float, high relative volume
Intellectia · 245 candidates
Relative Vol: >= 2Shares Outstanding: <= 50,000,000
Ticker
Name
Market Cap$
top bottom
GITS logo
GITS
Global Interactive Technologies Inc
6.25M
PAVM logo
PAVM
PAVmed Inc
11.92M
NAMM logo
NAMM
Namib Minerals
121.31M
SLGB logo
SLGB
Smart Logistics Global Ltd
75.44M
FRGT logo
FRGT
Freight Technologies Inc
2.66M
LSTA logo
LSTA
Lisata Therapeutics Inc
35.55M
What Low Fload Stocks are surging Now
Intellectia · 24 candidates
Price Change Pct: >= $10.00Relative Vol: >= 2Shares Outstanding: <= 20,000,000
Ticker
Name
Market Cap$
top bottom
NAMM logo
NAMM
Namib Minerals
121.31M
GITS logo
GITS
Global Interactive Technologies Inc
6.25M
LSTA logo
LSTA
Lisata Therapeutics Inc
35.55M
MLEC logo
MLEC
Moolec Science SA
4.71M
BOXL logo
BOXL
Boxlight Corp
1.73M
PAPL logo
PAPL
Pineapple Financial Inc
1.90M
increase the range for $0.12-$1.20
Intellectia · 13 candidates
Price: $0.12 - $1.20Volume: >= 3,000,000Relative Vol: >= 1.50List Exchange: XNAS
Ticker
Name
Market Cap$
top bottom
HUMA logo
HUMA
Humacyte Inc
189.14M
LUCD logo
LUCD
Lucid Diagnostics Inc
148.14M
ONCY logo
ONCY
Oncolytics Biotech Inc
125.90M
ELBM logo
ELBM
Electra Battery Materials Corporation
97.40M
CUE logo
CUE
Cue Biopharma Inc
34.28M
SURG logo
SURG
Surgepays Inc
25.72M
i want you to find penny stocks $0.12-$.80
Intellectia · 9 candidates
Price: $0.12 - $0.80Volume: >= 3,000,000List Exchange: XNASIs Optionable: False
Ticker
Name
Market Cap$
top bottom
IXHL logo
IXHL
Incannex Healthcare Inc
123.43M
PSTV logo
PSTV
Plus Therapeutics Inc
52.05M
MOBX logo
MOBX
MOBIX LABS, INC.
22.07M
IOBT logo
IOBT
IO Biotech Inc
14.94M
JTAI logo
JTAI
Jet.AI Inc
5.42M
AREB logo
AREB
American Rebel Holdings Inc
3.47M
rerun scenario
Intellectia · 14 candidates
Market Cap: <= 2.00BPrice: <= $5.00Volume: >= 1,000,000Price Change Pct: >= $2.00Relative Vol: >= 1.10Rsi 14: <= 50Shares Outstanding: <= 50,000,000
Ticker
Name
Market Cap$
top bottom
EMPD logo
EMPD
Empery Digital Inc
168.58M
SAVA logo
SAVA
Cassava Sciences Inc
104.83M
THH logo
THH
TryHard Holdings Ltd
38.04M
BRLS logo
BRLS
Borealis Foods Inc
25.33M
COSM logo
COSM
Cosmos Health Inc
19.42M
SGBX logo
SGBX
Safe & Green Holdings Corp
9.27M
penny stocks that will be bullish tomorrow
Intellectia · 9 candidates
Price: <= $5.00Relative Vol: >= 1.20Rsi 14: <= 40Moving Average Relationship: PriceCrossAboveMA5, PriceAboveMA20
Ticker
Name
Market Cap$
top bottom
BRCC logo
BRCC
BRC Inc
247.13M
ZENV logo
ZENV
Zenvia Inc
47.05M
BRLS logo
BRLS
Borealis Foods Inc
25.33M
FATBB logo
FATBB
FAT Brands Inc
20.09M
FGL logo
FGL
Founder Group Ltd
2.79M
FRGT logo
FRGT
Freight Technologies Inc
2.66M
best under .5 stock to jump tomorrow
Intellectia · 8 candidates
Price: <= $0.50Relative Vol: >= 0.800Moving Average Relationship: PriceAboveMA5Week Price Change Pct: >= $-15.00
Ticker
Name
Market Cap$
top bottom
IBO logo
IBO
Impact Biomedical Inc
52.31M
PSTV logo
PSTV
Plus Therapeutics Inc
52.05M
CUE logo
CUE
Cue Biopharma Inc
34.28M
GSIW logo
GSIW
Garden Stage Ltd
31.74M
KLTO logo
KLTO
Klotho Neurosciences Inc
24.27M
CAPT logo
CAPT
Captivision Inc
16.16M

Whales Holding XWEL

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is XWELL Inc (XWEL) stock price today?

The current price of XWEL is 1.45 USD — it has increased 7.41

What is XWELL Inc (XWEL)'s business?

XWELL, Inc. is a global wellness holding company. The Company operates through four segments: XpresSpa, XpresTest, Naples Wax Center and Treat. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresCheck segment, in partnership with the Centers for Disease Control and Prevention (CDC) and Ginkgo Biosecurity, conducts biosurveillance monitoring in its airport locations. XpresTest’s HyperPointe business provides a range of service and support options for its customers, including technical support services and advanced services. The Naples Wax Center segment operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products. The Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers.

What is the price predicton of XWEL Stock?

Wall Street analysts forecast XWEL stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for XWEL is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is XWELL Inc (XWEL)'s revenue for the last quarter?

XWELL Inc revenue for the last quarter amounts to 7.34M USD, decreased -12.79

What is XWELL Inc (XWEL)'s earnings per share (EPS) for the last quarter?

XWELL Inc. EPS for the last quarter amounts to -0.26 USD, decreased -73.74

How many employees does XWELL Inc (XWEL). have?

XWELL Inc (XWEL) has 246 emplpoyees as of March 06 2026.

What is XWELL Inc (XWEL) market cap?

Today XWEL has the market capitalization of 8.36M USD.